Does your congenital CMV test provide same-day results?
Meridian's Corporate Sponsored Session at SCASM 2022 will cover the challenges of testing and diagnosing congenital CMV
-
Review of congenital CMV infection which affects 1 in 200 babies, and how early detection can positively impact the health outcome of a child
-
Review of testing algorithms within the first 21 days of life, and the advantages/disadvantages of sample types: saliva, urine, and blood (DBS)
-
Learn about the only FDA-cleared molecular saliva-based test that delivers accurate results in less than 1 hour with minimal hands-on time and a simple procedure, while providing flexibility to best fit the laboratory’s workflow when compared to other testing technologies.
-
Learn why saliva is the preferred sample type and how it allows for optimal detection AND same-day reporting for physicians and families before the baby goes home
Session: “The Challenging Task of Diagnosing Congenital CMV”
Date: Saturday, October 22
Time: 7:45 am – 8:45 am
Location: Hyatt Regency Hotel - Encinitas 2
Congenital CMV is the #1 cause of non-genetic hearing loss in children. It is more common than all the targets in the newborn screen panel combined, yet it has the least amount of awareness compared to other congenital infections.
